Comparative antiplatelet activity of COX1 NSAIDS versus aspirin, encompassing regimen simplification and gastroprotection: a call for a controlled study
The cardioprotective/platelet inhibitory role of non-steroidal antiinflammatory drugs (NSAIDs) has been controversial, perhaps in contrast to the accepted prophylactic role of aspirin (114). That cardioprotective effect is attributed to the platelet aggregation inhibitory effects of aspirin and COX...
Saved in:
Main Author: | B. Rothschild (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2004-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gastric and renal effects of COX-2 selective and non-selective NSAIDs in rats receiving low-dose aspirin therapy
by: Marcella Goetz MORO, et al. -
Anticancer, antiplatelet, gastroprotective and hepatoprotective effects of camel urine: A scoping review
by: Norizam Salamt, et al.
Published: (2021) -
Dissolvable polymeric microneedles loaded with aspirin for antiplatelet aggregation
by: Baorui Wang, et al.
Published: (2023) -
Mapping the antiplatelet effects of clopidogrel and aspirin by modified thromboelastography
by: Hemlata, et al.
Published: (2013) -
NSAIDs, Mitochondria and Calcium Signaling: Special Focus on Aspirin/Salicylates
by: Yoshihiro Suzuki, et al.
Published: (2010)